Events
May 2026
Advanced Chemical & Biotech Patent Institute - San Francisco, USA
11 - 12 May
The 2026 Advanced Chemical & Biotech Patent Institute is a continuing legal education programme for experienced patent practitioners in the fields of chemistry and biotechnology. As part of the lead-up to the AIPLA 2026 Spring Meeting, it offers an in-depth overview from both prosecution and litigation perspectives, covering crucial topics relevant to practice in the U.S. and internationally. HOFFMANN EITLE is also a sponsor of this event. Within the programme, HOFFMANN EITLE partners Morten Garberg and Chloe Holloway will each contribute to dedicated sessions, with Morten speaking in “UPC and Implications for Chemical Practice”, offering insights into the evolving impact of the Unified Patent Court on chemical and biotech patent strategy, and Chloe moderating “Global Perspective on Clinical Trials”.
AIPLA 2026 Spring Meeting - San Francisco, USA
13 - 15 May
The AIPLA 2026 Spring Meeting is one of the key annual gatherings for intellectual property professionals, bringing together practitioners from private practice, industry, and academia to discuss current developments and emerging trends in IP law and practice. This year’s theme,“The Future of IP in an AI-Driven World: Opportunities and Safeguards,” underscores the relationship between innovation and intellectual property law within an evolving technological landscape. The programme offers a wide range of sessions covering patent, trade mark, and copyright law, as well as policy and practice updates, alongside numerous opportunities for professional exchange and networking. HOFFMANN EITLE partners Morten Garberg and Chloe Holloway will attend the Spring Meeting, where Morten will speak in the session titled “Due Care” and Patent Reinstatement Around the World.
June 2026
Life Science IP Seminar - Munich, Germany
9 - 11 June
For more than two decades, HOFFMANN EITLE hosts the Life Science IP Seminar every two years at its Munich office. The seminar addresses current topics in intellectual property protection for life science inventions and is widely regarded as an important forum for staying up to date with recent developments. It is characterised by the participation of a large number of experts from both industry and the legal profession.